Home
Storia in 1 fonti
VIDEO: Sacituzumab govitecan delays subsequent therapy in breast cancer subset
CHICAGO — In this video, Sara A. Hurvitz, MD, FACP, discusses the ASCENT-03 study, which showed treatment with sacituzumab govitecan improved PFS and delayed subsequent therapy vs. chemotherapy in metastatic triple-negative breast cancer.Results of the trial, which compared sacituzumab govitecan (Trodelvy, Gilead Sciences) with chemotherapy in previously untreated patients who were
Raccontata da
healio.com
Timeline cronologica
- ·
VIDEO: Tucatinib extends PFS with no new safety signals in HER2-positive breast cancer
CHICAGO — In this video, Erika P. Hamilton, MD, discusses results from the HER2CLIMB-05 trial of tucatinib in combination with trastuzumab and pertuzumab as first-line maintenance…
- ·
VIDEO: Sacituzumab govitecan delays subsequent therapy in breast cancer subset
CHICAGO — In this video, Sara A. Hurvitz, MD, FACP, discusses the ASCENT-03 study, which showed treatment with sacituzumab govitecan improved PFS and delayed subsequent therapy…